Inner Balance, LLC – Trademark Portfolio
Entity Type: 16
Inner Balance, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 4 are pending. Notable registered marks include OESTRA and BODY MATCHED. The owner is based in Boise, ID.
827 E Park Blvd
Suite 200
Boise, ID 83712
Showing of trademarks Trademarks
Trademark Classifications
Inner Balance, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Inner Balance, LLC have?
Inner Balance, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 pending, 1 cancelled.
What trademark classes does Inner Balance, LLC file in?
Inner Balance, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 14 (Jewelry). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Inner Balance, LLC's most well-known trademarks?
Inner Balance, LLC's registered trademark portfolio includes well-known marks such as OESTRA and BODY MATCHED. These are among 2 currently registered trademarks in the portfolio.
What is Inner Balance, LLC's trademark registration success rate?
Inner Balance, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.